BUSEP Q1 2026 Earnings EPS Exceeds Estimates by 1316 NMTC Q1 2026 Earnings EPS Misses Estimates Stock Declines as Company Continues Development Phase DRTS Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Company Continues Clinical Development ZSPC Q1 2026 Earnings Significant EPS Miss as Revenue Remains Undisclosed AMTB Q1 2026 Earnings EPS Slightly Below Estimates Shares Edge Higher Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum PDCC Q4 2025 Earnings EPS Misses Estimates Shares Edge Lower Plus500 Reports 11 Revenue Growth Reaffirms FullYear Expectations